NA Proactive news snapshot: Exactus, Media Central Corp, Biocept, Loop Insights ...

Exactus Inc (OTCMKTS:EXDI), which farms and manufactures hemp-derived cannabidiol (CBD) products, announced on Tuesday that it has launched its genetics division to supply farmers with US Food and Drug Administration (FDA) compliant feminized CBD and cannabigerol (CBG) hemp seeds The Florida-based company said it is “proud” to expand its product portfolio to become a “reliable source for farmers,” while continuing to provide the industry with hemp-derived CBD, CBG, cannabinol (CBN), cannabichromene (CBC), and other specialty cannabinoids. The new genetics division is inspired by the company’s over 20 years of agricultural experience. Media Central Corporation Inc (CSE:FLYY) announced on Tuesday that it has struck an alliance with Canadian telehealth service giant Tia Health to provide its readers access to a vast network of physicians through videoconferencing, electronic consultations and virtual communication. The Toronto-based media giant said that thanks to the alliance with Tia Health, readers will be able to access healthcare they need from their home, without worrying about putting themselves or others at risk during the coronavirus (COVID-19) outbreak. Tia Health services are provided free with a valid health card in Ontario, Alberta, and British Columbia, and include: online appointments with Canadian doctors, prescriptions, referrals, requisitions, mental health support, on-demand test requisitions and results, prescriptions and renewals delivered right to the door. Biocept Inc (NASDAQ:BIOC), a commercial developer of liquid biopsy tests, announced Tuesday that its Target Selector molecular assay EGFR kit has earned a CE-IVD (in-vitro diagnostic) mark from European regulators. The designation allows Biocept to sell its kits throughout the European Union and other CE mark geographies. The kits are able to detect key oncogene mutations by analyzing tissue taken through surgical biopsies and circulating tumor DNA (ctDNA) gained from blood-based liquid biopsies. Mutations in what’s known as the EGFR pathway are frequent biomarkers for lung cancer, and identifying them can help guide treatment decisions, the company said.  Loop Insights Inc (CVE:MTRX) (OTCPINK:VRZPF) is boosting its board of advisors with the appointment of Jeffrey Hyman, a veteran Wall Street investment banker. Hyman, who brings over 20 years of finance experience to the firm, led large-scale development projects in the US in the hospitality and infrastructure sectors. Vancouver-based Loop told shareholders that Hyman’s experience aligns well with the technology company’s client base. Exro Technologies Inc (CSE:XRO) (OTCMKTS:EXROF) has revealed it is further commercializing its technology as it unveiled a tie-up with Toronto-listed Clean Seed Capital Group Ltd (CVE:CSX) to enhance the latter's high-tech agricultural seeder and planter platforms. The pair will produce a working prototype to be implemented in the field by 2021 so farmers will be able to reduce power needed to run Clean Seed's revolutionary farm tools, the company said. Exro is focused on the world’s transition to clean energy by providing products, which increase the efficiency and reliability of power systems, including electric motors, generators and batteries. Hillcrest Petroleum Ltd (CVE:HRH) (OTCMKTS:HLRTF) has reported further progress on the cleantech opportunity it announced earlier this month. As revealed on April 23, the junior oiler has struck a deal to co-market, with Oropass Ltd, the licensing in the USA for a patented, electrical generation technology. Now, Hillcrest said it has made the cash deposit to secure the exclusive right to become a partner. mCloud Technologies Corp (CVE:MCLD) (OTCMKTS:MCLDF), the IoT and AI specialist, has reported an 18% increase in assets on its platform in the first quarter of 2020 compared to fourth quarter 2019 and revealed it has a new solution to help restaurants and retailers get back to business amid the coronavirus (COVID-19) pandemic. In an update on Tuesday, the tech group said it had grown its count of connected assets to 48,672 in the first three months of the year, having reported at the end of March that it had connected assets of over 41,000 by year-end 2019. Champignon Brands Inc (CSE:SHRM) (OTCQB:SHRMF) revealed that it has been selected as a headline partner for a major psychedelics conference to be held virtually in June. The Vancouver-based company said that it will act as a main partner for the PSYCH: The Psychedelics Symposium, which is scheduled to run between June 22 to 23, 2020. Champignon specializes in formulizing a suite of medicinal mushroom health products and ketamine to treat a broad range of disorders. Matinas BioPharma Holdings, Inc. (NYSEAMERICAN:MTNB), a clinical-stage biopharmaceutical company focused on development of its lead product candidate, MAT9001, for the treatment of cardiovascular and metabolic condition, announced that its chief executive officer, Jerome D. Jabbour has been invited to participate in a panel discussion, as well as host investor meetings, during the Maxim Group Infectious Disease Virtual Conference on Tuesday, May 5, 2020. It said the panel discussion with a select group of infectious disease companies, entitled 'Antifungals', will be moderated by Maxim Group analyst, Jason McCarthy, and take place at 12.15pm-1.45pm. The group said a live audio webcast of the panel discussion will be available on the events page of the Investors section of the company’s website -www.matinasbiopharma.com - and a webcast replay will be accessible for 90 days following the live presentation. Investors interested in arranging a virtual meeting with the company's management during this conference should contact the conference coordinator, Soraya Dorce at sdorce@maximgrp.com. Endeavour Mining (TSX:EDV) (OTCQX:EDVMF) has said it will release its financial results for the first quarter of 2020 on Wednesday, May 13, before the TSX market open. The group also said its management will host a conference call and webcast on the same day at 8.30am Toronto time (ET) to discuss the financial results. The webcast can be accessed through the link: https://edge.media-server.com/mmc/p/wzt8x39v. Analysts and investors are also invited to participate and ask questions using the dial-in numbers: International: +1 646-741-3167; North American toll-free: +1 877-870-9135; UK toll-free: 0800-279-6619; Confirmation Code: 3666389. The conference call and webcast will also be available for playback on Endeavour's website. Medgold Resources Corp. (CVE:MED) has announced that it is relying on the extension provided by the securities regulators as a result of the coronavirus (COVID-19) pandemic regarding the deadline for filing and delivering its audited financial statements and MD&A for the fiscal year ended December 31, 2019. Accordingly, the company said, it will file such financials no later than the extended deadline of June 15, 2020. Until the financials are filed, the company added, it's management and directors are subject to a trading black-out. It also confirmed that there have been no unannounced material business developments since the company filed its September 30, 2019 interim financial reports.